Jennifer brings over 25 years of neuroscience research experience from MIT (B.S.), Yale (Ph.D.) and the Rockefeller University (post-doctoral fellowship), where she worked closely with Ron Duman - who proposed the neurotrophic hypothesis of antidepressant activity- and Nobel Laureate Paul Greengard, studying neuropsychiatric diseases at molecular, cellular and behavioral levels. Prior to joining Transcend, Jennifer was the Director of R&D at Magnolia Neurosciences.
February, 2022 - present
Chief Scientific Officer at Biomemory
SVP for Research at Penn State University
Chief Behavioral Science Officer And President Americas at Mind Gym
Chief Research & Development Officer at Fate Therapeutics
President & Chief Science Officer at NULASTIN
Access the worlds's biggest network of public org charts
Learn more